In the late 1990 s outstanding pharmaceutical intermediates industry has been basically mature, the competition between enterprises has reached a climax in the last ounce of power, who can hold out until the last of the survivors who are at the same time the temptation of all kinds of legends and other factors, there are new investors "gold rush" dream into the industry, but as the country requires companies GMP certification and accreditation geometric scale of various overseas investment in the rise of the medical industry, how to make the limited funds and energy to produce the greatest economic benefits and social benefits has become every investor for pharmaceutical intermediates.